Efficacy and safety of efalizumab in patients with moderate-to-severe plaque psoriasis resistant to previous anti-psoriatic treatment: results of a multicentre, open-label, Phase IIIb/IV trial - Lotti, T.; Chimenti, S.; Katsambas, A (Arch Drug Info, 2010)